FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Topics >> brain cancer

Personalized brain cancer vax tested in humans

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools

An experimental brain cancer vaccine developed at Duke University is being tested on patients at Duke and St. Vincent's Medical Center in Jacksonville, FL. The vaccine is made by extracting white blood cells from the patient and then mixing it with DNA that includes the genetic mutations that triggered the glioblastoma. "We think a significant reason these tumors are so hard to treat to begin with is they are so good at evading the immune system," said Kent New, the head of neurosurgery at an affiliate of St. Vincent's. New trained with Duke's John Sampson, who developed the personalized vaccine. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about brain cancer  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.